Medical Device News

What are the future trends of medical devices?  In the rapidly evolving landscape of healthcare, staying informed about the latest advancements in medical technology is essential for professionals and enthusiasts alike. Medical Device News Magazine serves as a vital resource, offering insights into cutting-edge innovations, regulatory developments, and industry trends that impact both patient care and business strategies. This publication aims to bridge the gap between healthcare professionals, investors, and the medical device industry, providing a comprehensive platform of medical device news that can result in discussions on medical device/biotechnology advancements and their implications for the future of medicine.

Read on as we explore the intersection of technology and healthcare, facilitating informed decision-making and fostering collaboration within this dynamic field. Inquire about advertising. Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

Industry Expert Byline

Bariatric Surgery: Balancing Medications and Surgical Interventions

Discover how new weight loss medications like Ozempic are reshaping bariatric surgery practices. Dr. Monique Hassan discusses surgical innovations, treatment costs, and the future of obesity care in this comprehensive interview.

Medical Device News Updates

Luna Partners with Leading Academic Medical Center | To Expand Access to In-home, Outpatient PT Services

Luna advises the new collaboration will start taking appointments in February 2025, and patients seeking care will receive safe, high-quality PT conveniently delivered to their homes.

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Mergers & Acquisitions & Funding

Poseida Therapeutics Announces Agreement to be Acquired by Roche Holdings, Inc.

The proposed acquisition will establish a new core capability for Roche in allogeneic cell therapy, with lead opportunities focused on CAR-T programs covered by the existing strategic collaboration between Poseida and Roche in hematologic malignancies. It will include CAR-T programs for solid tumors and autoimmune diseases, along with Poseida's genetic engineering platform and related preclinical medicines.

Cytomos Secures £5M | To Scale Up Production of Cell-analysis Technology

New investment will allow Cytomos to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction.

Clinical Trials & Updates

SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS

"These outstanding results underscore the potential of the Histolog Scanner to enhance oncologic surgical outcomes significantly," said Olivier Delporte, CEO of SamanTree Medical. "By enabling real-time, high-resolution tissue microstructure assessments during BCS, our technology addresses a critical unmet need, reducing reoperation rates and improving patient outcomes.

New Data From SonarMD Finds that Anxiety Increases Risks for Inflammatory Bowel Disease Flares and Disease Severity

“These findings demonstrate that mental health factors like anxiety play a critical role in the clinical course of IBD,” said Beth Houck, CEO, SonarMD “By identifying and addressing psychological contributors, we can refine value-based care models to better support patients with chronic digestive diseases. Integrated care models that incorporate mental health screening and interventions should be considered a standard for high-quality IBD care.”

Byline Articles

Bariatric Surgery: Balancing Medications and Surgical Interventions

Discover how new weight loss medications like Ozempic are reshaping bariatric surgery practices. Dr. Monique Hassan discusses surgical innovations, treatment costs, and the future of obesity care in this comprehensive interview.

Biotechnology News

Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in...

Eisai and Biogen Japan will continue to contribute to the advancement of Alzheimer’s disease treatment through ongoing collaboration with academia.

Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial (“INVINCIBLE-3 Study”) in...

Phase 1/2 data showed a median overall survival (“mOS”) of 21.3 months versus a synthetic control of 6.7 months, an increase in T-cell activation, and favorable safety profile for patients receiving INT230-6 alone notes Intensity Therapeutics.

FDA Updates

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDEÒ Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

Christopher M. Owens, President and Chief Executive Officer of R3 Vascular. “Initiation of this trial will begin in Q1 2025 and will be conducted at up to 60 global clinical sites with 264 subjects, and upon favorable conclusion will allow the company to complete and pursue a PMA market application for MAGNITUDE with the FDA.”

Exactech Reports the FDA Clearance of Truliant® Porous 3D Tibial Implant for Knee Replacement Surgery

The Truliant Porous Tibial Tray leverages additive manufacturing technology to create a porous structure designed to mimic the structure of cancellous bone. This design aims to facilitate both initial and biological fixation, designed to accommodate patients' active lifestyles notes Exactech.

Headlines

Philips and AWS Expand Strategic Collaboration to Advance HealthSuite Cloud Services and Power Generative AI Workflows

“The collaboration between Philips and AWS gives healthcare providers scalable, secure-by-design cloud-enabled solutions to accelerate healthcare innovation,” said Matt Garman, CEO of AWS. “Combining Philips’ healthcare informatics portfolio with AWS generative AI capabilities gives clinicians access to imaging insights so they can deliver more effective and efficient care to patients anywhere, anytime, with best-in-class security and privacy.”

Elucid Announces Fifth Medicare Administrative Contractor to Cover AI Coronary Plaque Analysis

“This latest expansion of coverage by Noridian means that even more patients could be positively impacted by PlaqueIQ, which offers the only non-invasive measurement of lipid-rich necrotic core, a vulnerable, high-risk component of plaque that can lead to heart attack and stroke,”4 said Kelly Huang, CEO of Elucid. “These recent decisions from five of the seven MACs recognize the importance of new technologies like ours that can help quantify and classify coronary artery plaque to help physicians reduce the clinical and economic burden of cardiovascular disease.”

Hospitals In the News

The Northwell Health Constellation Gala Raises More Than $3.2M To Support Health Care Innovation In Manhattan

This year’s event was hosted by actress and comedian Cecily Strong and featured a musical performance by the Orchestra of St. Luke’s. Proceeds will provide greater access to high-quality care by helping to advance services and programs across Manhattan at Lenox Hill Hospital, Manhattan Eye, Ear & Throat Hospital, Lenox Health Greenwich Village  – and soon, the Victoria and Lloyd Goldman Health Care Pavilion, a state-of-the-art outpatient care facility that is slated to open on the Upper East Side in 2026.

Executives Making Headlines

Paul Ziegler Appointed President and CEO of Augmedics

“I am thrilled to join the Augmedics team and build on the foundation they’ve established as the leading spine-based AR platform on the market,” said Paul Ziegler. “I am excited and honored to lead the company through this next phase of growth as we capitalize on the game-changing potential of xvision to make spine surgery safer, simpler, and more reproducible.”

Nusano Names Medical Radioisotopes Advisory Board

“As a radioisotope producer, Nusano plays a critical role in the supply chains of drug developers, healthcare providers and researchers,” said Chris Lowe, CEO of Nusano. “Establishing a Medical Radioisotopes Advisory Board reflects our ongoing commitment to proactively enabling the next generation of oncology research. The board’s guidance will ensure Nusano is providing a stable and scalable supply of isotopes for new areas of research and patient care.”

Non-Profit Updates

Non Profit News

Vision-based ChatGPT Shows Deficits Interpreting Radiologic Images

The study’s results were published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Cold Weather Exposure Linked to Increased Risk of Heart Attacks

JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, said the study reveals a crucial link between cold weather exposure and heart attack risk, highlighting a delayed effect that peaks days after the cold spell.

Ryan Reynolds Announces More to Parkinson’s® Campaign

Ryan Reynolds said, “My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease. Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease.”

New Paper Underscores Inflammation’s Role in Atherosclerosis

Peter Libby, MD, President, of the International Atherosclerosis Society and Chair of the White Paper Expert Panel said, "Atherosclerosis is a primary cause of cardiovascular disease, the leading cause of death worldwide. This paper underscores the persistent need for a more complete understanding of the role of inflammation in atherosclerosis progression among physicians globally, how to identify such inflammation, and how to mitigate the inflammation-associated risk of adverse cardiovascular events. These steps are of the utmost importance for the development of effective treatment strategies that can reduce the morbidity and mortality caused by atherosclerotic cardiovascular disease."

Subscribe to Medical Device News Magazine

Other News

Exit mobile version